Article
PPARα as a therapeutic target in inflammation-associated diseases
27 Aug 2012
Abstract excerpt
INTRODUCTION: The nuclear receptor peroxisome proliferator-activated receptor alpha (PPARα) plays a major regulatory function of genes involved in energy metabolism and is a therapeutic target for dyslipidemia. The last decade provided a constellation of findings demonstrating that PPARα behaves as a modulator of both acute and chronic inflammation. PPARα became a rational potential therapeutic target for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
